Cutaneous adverse drug reactions seen at a University Hospital Department of Dermatology

Acta Dermato-Venereologica

Volumn 86, Issue 6, 2006, Pages 523-527

  Borch, Jakob E ^a   Andersen, Klaus E ^a   Bindslev Jensen, Carsten ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cutaneous adverse drug reaction; Drug allergy; Drug eruptions; Epidemiology; Pharmaco vigilance

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CETIRIZINE; CIPROFLOXACIN; CYCLOSPORIN; CYTARABINE; DICLOFENAC; DICLOXACILLIN; ENALAPRIL; ESOMEPRAZOLE; GRASS EXTRACT; HEPARIN; HEPATITIS B VACCINE; IBUPROFEN; INSULIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PEGINTERFERON ALPHA2A; PENICILLIN G; PERINDOPRIL; PHENYLEPHRINE; PLANT EXTRACT; RIBAVIRIN; SPIRONOLACTONE; TRANDOLAPRIL;

ADULT; AGED; ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BULLOUS PEMPHIGOID; CHILD; CONTROLLED STUDY; DERMATITIS; DESENSITIZATION; DRUG ERUPTION; ECZEMA; FEMALE; GINGIVA HYPERPLASIA; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PURPURA; RASH; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL; URTICARIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; DENMARK; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; EXANTHEMA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PLANT EXTRACTS; PREVALENCE; RETROSPECTIVE STUDIES; URTICARIA;

EID: 33845665849     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0153     Document Type: Article

References (24)

1. Gardner P, Cluff LE. The epidemiology of adverse drug reactions. A review and perspective. Johns Hopkins Med J 1970; 126: 77-87.
2. Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-68.
3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
4. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-1022.
5. Borch JE, Andersen KE, Bindslev-Jensen C. Prevalence of acute cutaneous drug reactions in a university hospital. Acta Derm Venereol, in press.
6. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; 2: 1056-1058.
7. Skov PS, Mosbech H, Norn S, Weeke B. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985; 40: 213-218.
8. EAACI. Position paper: allergen standardization and skin tests. Report No. 48 suppl. Copenhagen: Munksgaard, 1993.
9. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
10. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328.
11. Wahlberg JE, Lindberg M. Patch testing. In: Frosch PJ, Menne T, Lepoittevin J-P, eds. Textbook of contact dermatitis, 4th edn. Berlin: Springer Verlag, 2006: p. 365-390.
12. Romagosa R, Kapoor S, Sanders J, Berman B. Inpatient adverse cutaneous drug eruptions and eosinophilia. Arch Dermatol 2001; 137: 511-512.
13. Neukomm CB, Yawalkar N, Helbling A, Pichler WJ. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001; 11: 275-284.
14. Ordoqui E, Zubeldia JM, Aranzabal A, Rubio M, Herrero T, Tornero P, et al. Serum tryptase levels in adverse drug reactions. Allergy 1997; 52: 1102-1105.
15. Veien M, Szlam F, Holden JT, Yamaguchi K, Denson DD, Levy JH. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology 2000; 92: 1074-1081.
16. Zhao Z, Baldo BA, Baumgart KW, Mallon DF. Fine structural recognition specificities of IgE antibodies distinguishing amoxicilloyl and amoxicillanyl determinants in allergic subjects. J Mol Recognit 2001; 14: 300-307.
17. Moreno F, Blanca M, Mayorga C, Terrados S, Moya M, Perez E, et al. Studies of the specificities of IgE antibodies found in sera from subjects with allergic reactions to penicillins. Int Arch Allergy Immunol 1995; 108: 74-81.
18. Demoly P, Lebel B, Messaad D, Sahla H, Rongier M, Daures JP, et al. Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 1999; 54: 500-506.
19. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.
20. Borch JE, Bindslev-Jensen C. Udredning af penicillin-allergi. Procedurer og retrospektiv opgørelse af resultater for perioden 1997-2001. [Investigation of penicillin allergy. Procedures and retrospective statement of results for the period 1997 to 2001]. Ugeskr Laeger 2003; 165: 3157-3161.
21. Torres MJ, Blanca M, Fernandez J, Romano A, Week A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-972.
22. Borch JE, Andersen KE, Clemmensen O, Bindslev-Jensen C. Drug induced bullous pemphigoid with positive patch-test and in vitro IgE-sensitization. Acta Derm Venereol 2005; 85: 171-172.
23. Deleuran M, Clemmensen O, Andersen KE. Contact lupus erythematosus. Contact Dermatitis 2000; 43: 169-170.
24. Borch JE, Bindslev-Jensen C. Delayed-type hypersensitivity to heparins. Allergy 2004; 59: 118-119.